RxSight, Inc.
General ticker "RXST" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $790.9M (TTM average)
RxSight, Inc. does not follow the US Stock Market performance with the rate: -7.9%.
Estimated limits based on current volatility of 2.9%: low 11.77$, high 12.48$
Factors to consider:
- Total employees count: 498 (+33.2%) as of 2024
- Top business risk factors: Operating losses, Dependence on rxsight system, Capital raising, Limited operating history, Market competition
- Current price 42.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [21.84$, 49.10$]
- 2025-12-31 to 2026-12-31 estimated range: [17.25$, 39.45$]
Financial Metrics affecting the RXST estimates:
- Negative: with PPE of -85.5 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1.24 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 88.28 > 63.39
- Positive: Inventory ratio change, % of -2.82 <= -0.75
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Net income
- Positive: -14.38 < Investing cash flow per share per price, % of -7.29
Short-term RXST quotes
Long-term RXST plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $49.01MM | $89.08MM | $139.93MM |
| Operating Expenses | $112.32MM | $139.16MM | $176.78MM |
| Operating Income | $-63.32MM | $-50.09MM | $-36.86MM |
| Non-Operating Income | $-3.43MM | $1.50MM | $9.45MM |
| Interest Expense | $4.95MM | $3.31MM | $0.02MM |
| R&D Expense | $25.98MM | $29.05MM | $34.37MM |
| Income(Loss) | $-66.75MM | $-48.59MM | $-27.41MM |
| Taxes | $0.01MM | $0.02MM | $0.05MM |
| Profit(Loss)* | $-66.76MM | $-48.61MM | $-27.45MM |
| Stockholders Equity | $89.90MM | $160.36MM | $281.24MM |
| Inventory | $14.84MM | $17.42MM | $22.01MM |
| Assets | $150.16MM | $182.55MM | $318.56MM |
| Operating Cash Flow | $-58.85MM | $-41.59MM | $-16.95MM |
| Capital expenditure | $2.39MM | $4.81MM | $5.44MM |
| Investing Cash Flow | $39.95MM | $-22.13MM | $-99.31MM |
| Financing Cash Flow | $6.33MM | $61.52MM | $123.32MM |
| Earnings Per Share** | $-2.41 | $-1.41 | $-0.71 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.